EUVIMEDEUVIMED entdecken
Crossref

Inhibition of DNA glycoxidation by mannitol and Pyridoxamine: Implications for DNA-antibody development in diabetes and diabetic retinopathy

Rihab Akasha, Uzma Shahab, Ramendra Pati Pandey, Saif Khan, Paridhi Puri, Zeeshan Rafi, Sultan Alouffi, Saheem Ahmad

Analytical Biochemistry · 2025

DOI: 10.1016/j.ab.2025.115886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2025. Verfasst von Rihab Akasha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, 2440, Saudi Arabia. Electronic address: rih…. Hauptthemen laut MEDLINE: Pyridoxamine, Mannitol, DNA, Diabetic Retinopathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Australasian Gynaecological Endoscopy and Surgery Society, University of Hail.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic exposure to reactive carbonyl species such as glyoxal and methylglyoxal, along with hydroxyl radicals (•OH), leads to glycative and oxidative damage, contributing to insulin resistance and diabetic complications. Pyridoxamine (PM) is known to counteract these effects, but its potential synergy with mannitol (MN), a hydroxyl radical scavenger, remains unexplored. This study investigates the combined efficacy of MN and PM in preventing glycation and oxidative damage in vitro. Calf thymus DNA was subjected to glycation using 10 mM glyoxal, oxidation via the Fenton reaction, and sequential glycoxidation (glycation followed by oxidation). The inhibitory effects of MN, PM, and their combination were assessed using NBT reduction for early glycation, GK-ribose for AGEs, TBARS for hydroxyl radicals, and spectroscopic analyses for AGEs formation. A clinical study also examined autoantibody prevalence in diabetes and diabetic retinopathy (DR). Results showed that glycoxidated DNA exhibited structural alterations, with MN and PM individually reducing ketoamine content. Their combination further enhanced glycation and glycoxidation inhibition. Additionally, MN-PM co-administration synergistically reduced AGEs and hydroxyl radicals. Autoantibody levels were elevated in diabetes and DR. These findings suggest PM-MN co-administration as a promising strategy to mitigate diabetic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridoxamineMannitolDNADiabetic RetinopathyDiabetes MellitusAnimalsCattleHumansGlycosylationOxidation-ReductionGlycation End Products, AdvancedAutoantibodiesMaleFemale

Stichwörter der Autor:innen

Calf thymus DNAGlycationGlycoxidationHydroxyl radicalMannitolOxidized DNAPyridoxamine

Substanzen

PyridoxamineMannitolDNAcalf thymus DNAGlycation End Products, AdvancedAutoantibodies

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, 2440, Saudi Arabia. Electronic address: rihabakasha2000@yahoo.com.
  • Department of Pharmacology, College of Pharmacy, University of Hail, Hail City, 2440, Saudi Arabia. Electronic address: u.shahab@uoh.edu.sa.
  • Department of Biotechnology, SRM University, Delhi-NCR, Sonepat, Haryana, 131029, India. Electronic address: ramendra.pandey@gmail.com.
  • Department of Basic Dental and Medical Sciences, College of Dentistry, University of Hail, Saudi Arabia. Electronic address: saifkhan.bio@gmail.com.
  • University Centre for Research and Development, Chandigarh University, Mohali, Punjab, 140413, India. Electronic address: paridhi.e14948@cumail.in.
  • Department of Bioengineering, Integral University, Lucknow, 226026, India. Electronic address: zeddqazi@gmail.com.

Förderung

  • Australasian Gynaecological Endoscopy and Surgery Society
  • University of Hail

Zitieren

APA

Akasha, R., Shahab, U., Pandey, R. P., Khan, S., Puri, P., Rafi, Z., Alouffi, S., & Ahmad, S. (2025). Inhibition of DNA glycoxidation by mannitol and Pyridoxamine: Implications for DNA-antibody development in diabetes and diabetic retinopathy. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2025.115886

Vancouver

Akasha R, Shahab U, Pandey RP, Khan S, Puri P, Rafi Z, et al. Inhibition of DNA glycoxidation by mannitol and Pyridoxamine: Implications for DNA-antibody development in diabetes and diabetic retinopathy. Analytical Biochemistry. 2025. doi:10.1016/j.ab.2025.115886

BibTeX
@article{Akasha2025,
  author = {Akasha, Rihab and Shahab, Uzma and Pandey, Ramendra Pati and Khan, Saif and Puri, Paridhi and Rafi, Zeeshan and Alouffi, Sultan and Ahmad, Saheem},
  title = {Inhibition of DNA glycoxidation by mannitol and Pyridoxamine: Implications for DNA-antibody development in diabetes and diabetic retinopathy},
  journal = {Analytical Biochemistry},
  year = {2025},
  doi = {10.1016/j.ab.2025.115886}
}
Kostenlos starten →